We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

600160:SSEZhejiang Juhua Co., Ltd. Class A Analysis

Data as of 2026-07-30 - not real-time

CN¥40.04

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Zhejiang Juhua trades at CNY 40.04, sitting below its 20‑day (42.08) and 50‑day (42.50) simple moving averages while remaining above the 200‑day average (38.14), indicating a short‑term pull‑back in a longer‑term uptrend. The MACD is bearish (line –1.51 vs signal –1.14) and volume is on a downtrend, suggesting limited upside momentum in the near term. Volatility is elevated at 74 % over the past 30 days and the beta is near zero, implying the stock moves independently of broader market swings. Valuation metrics show a trailing P/E of 26 versus a forward P/E of 16.9, and a DCF‑derived fair value of only CNY 25.3, flagging the stock as materially overvalued at current levels. Fundamentally, the company posts a solid ROE of 21 % and a healthy operating margin (26 %), but free cash flow is negative (‑CNY 1.0 bn) and the price‑to‑book ratio sits at 5×, reinforcing the overvaluation view.
Despite these pricing pressures, the firm delivers a 1.43 % dividend yield with a modest payout ratio of 27 %, indicating dividend sustainability. Revenue growth is modest (3.7 %) and the balance sheet is manageable with a debt‑to‑equity of 30.6 %. The business benefits from diversified end‑markets—including new‑energy and electronics—providing a stable long‑run demand backdrop. With a strong ROE, reasonable leverage, and a consistent dividend, the stock’s long‑term fundamentals remain attractive should the market price converge toward its intrinsic value.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish MACD and price below short‑term SMAs
  • Decreasing volume and high short‑term volatility
  • Current price still above near‑term support (36.78)

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Forward P/E of 16.9 signals earnings upside
  • Strong ROE and sustainable dividend yield
  • Overvaluation relative to DCF fair value

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Robust operating margins and diversified end‑markets
  • Solid cash‑flow generation despite short‑term negative free cash flow
  • Potential price correction toward DCF valuation

Key Metrics & Analysis

Financial Health

Revenue Growth3.70%
Profit Margin15.26%
P/E Ratio26.0
ROE21.05%
ROA10.49%
Debt/Equity30.61
P/B Ratio5.0
Op. Cash FlowCN¥6.7B
Free Cash FlowCN¥-1036169792

Technical Analysis

TrendNeutral
RSI44.6
SupportCN¥36.78
ResistanceCN¥54.68
MA 20CN¥42.08
MA 50CN¥42.50
MA 200CN¥38.14
MACDBearish
VolumeDecreasing
Fear & Greed Index84.54

Valuation

Fair ValueCN¥25.29
GradeOvervalued
TypeBlend
Dividend Yield1.43%

Risk Assessment

Beta-0.04
Volatility74.32%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.